Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Natco Pharma Ltd

NSE: NATCOPHARM · BSE: 524816 · Pharmaceuticals & Biotechnology · 36 announcements

Share price
₹810.10
Market cap
₹15,892 Cr
Revenue (annual)
₹4,078 Cr
Net profit (annual)
₹1,418 Cr
P/E (TTM)
13.9×Sector 47.3×
Promoter holding
49.42%+0.00% QoQ
FII holding
16.99%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

09:56 IST NSE
Legal & Regulatory

Natco Pharma Legal & Regulatory

Natco Pharma received a ₹0.60 Crore GST demand including interest and penalties. The order relates to RCM reporting discrepancies for the 2020-2024 period.

Value
₹0.60 Cr
16:17 IST NSE
Legal & Regulatory

Natco Pharma Legal & Regulatory

Natco Pharma received a ₹4.92 Crore demand notice from NPPA for alleged overcharging on two drugs. The company reports no material impact on its operations.

Value
₹4.92 Cr